(Press-News.org) New Rochelle, NY, April 17, 2014—The development of stem cell therapies to cure a variety of diseases depends on the ability to characterize stem cell populations based on cell surface markers. Researchers from the Finnish Red Cross have discovered a new marker that is highly expressed in a type of stem cells derived from human umbilical cord blood, which they describe in an article in BioResearch Open Access, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the BioResearch Open Access website.
Heli Suila and colleagues, Finnish Red Cross Blood Service, Helsinki, Finland present evidence to show that the glycan O-GLcNAc, is present on the surface of stem cells and is part of a stem cell-specific surface signature. In the article "Extracellular O-Linked N-Acetylglucosamine Is Enriched in Stem Cells Derived from Human Umbilical Cord Blood" the authors suggest that the glycan plays a crucial role in a cell signaling pathway that regulates embryonic development.
"This work is particularly interesting as epidermal growth factor domains are found on the Notch receptors, suggesting that these novel glycans may be involved in Notch receptor signaling pathways in stem cells," says BioResearch Open Access Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, University of Edinburgh, Scotland.
INFORMATION:
About the Journal
BioResearch Open Access is a bimonthly peer-reviewed open access journal led by Editor-in-Chief Robert Lanza, MD, Chief Scientific Officer, Advanced Cell Technology, Inc. and Editor Jane Taylor, PhD. The Journal provides a new rapid-publication forum for a broad range of scientific topics including molecular and cellular biology, tissue engineering and biomaterials, bioengineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, biochemistry, virology, microbiology, and neuroscience. All articles are published within 4 weeks of acceptance and are fully open access and posted on PubMedCentral. All journal content is available on the BioResearch Open Access website.
About the Publisher
Mary Ann Liebert, Inc., publishers, is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many areas of science and biomedical research, including, DNA and Cell Biology, Tissue Engineering, Stem Cells and Development, Human Gene Therapy, HGT Methods, and HGT Clinical Development, and AIDS Research and Human Retroviruses. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website (http://www.liebertpub.com).
Mary Ann Liebert, Inc. 140 Huguenot St., New Rochelle, NY 10801-5215 http://www.liebertpub.com
Phone: (914) 740-2100 (800) M-LIEBERT Fax: (914) 740-2101
Novel marker discovered for stem cells derived from human umbilical cord blood
2014-04-17
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Five anthropogenic factors that will radically alter northern forests in 50 years
2014-04-17
COLUMBIA, Mo. April 17 – In the most densely forested and most densely populated quadrant of the United States, forests reflect two centuries of human needs, values and practices. Disturbances associated with those needs, such as logging and clearing forests for agriculture and development, have set the stage for management issues of considerable concern today, a U.S. Forest Service study reports.
The report – Five anthropogenic factors that will radically alter forest conditions and management needs in the Northern United States – was published recently by the journal ...
CU researchers discover target for treating dengue fever
2014-04-17
AURORA, Colo. (April 17, 2014) – Two recent papers by a University of Colorado School of Medicine researcher and colleagues may help scientists develop treatments or vaccines for Dengue fever, West Nile virus, Yellow fever, Japanese encephalitis and other disease-causing flaviviruses.
Jeffrey S. Kieft, PhD, associate professor of biochemistry and molecular genetics at the School of Medicine and an early career scientist with the Howard Hughes Medical Institute, and colleagues recently published articles in the scholarly journals eLife and Science that explain how flaviviruses ...
Vitamin B3 might have been made in space, delivered to Earth by meteorites
2014-04-17
Ancient Earth might have had an extraterrestrial supply of vitamin B3 delivered by carbon-rich meteorites, according to a new analysis by NASA-funded researchers. The result supports a theory that the origin of life may have been assisted by a supply of key molecules created in space and brought to Earth by comet and meteor impacts.
"It is always difficult to put a value on the connection between meteorites and the origin of life; for example, earlier work has shown that vitamin B3 could have been produced non-biologically on ancient Earth, but it's possible that an added ...
Bright points in sun's atmosphere mark patterns deep in its interior
2014-04-17
Like a balloon bobbing along in the air while tied to a child's hand, a tracer has been found in the sun's atmosphere to help track the flow of material coursing underneath the sun's surface.
New research that uses data from NASA's Solar Dynamics Observatory, or SDO, to track bright points in the solar atmosphere and magnetic signatures on the sun's surface offers a way to probe the star's depths faster than ever before. The technique opens the door for near real-time mapping of the sun's roiling interior – movement that affects a wide range of events on the sun from ...
Lab researcher discovers the green in Greenland
2014-04-17
At one point in history, Greenland was actually green and not a country covered in ice.
An international team of researchers, including a scientist from Lawrence Livermore National Laboratory, has discovered that ancient dirt in Greenland was cryogenically frozen for millions of years under nearly two miles of ice.
More than 2.5 million years ago. Greenland looked like the green Alaskan tundra, before it was covered by the second largest body of ice on Earth.
The ancient dirt under the Greenland ice sheet helps to unravel an important mystery surrounding climate change: ...
Multitarget TB drug could treat other diseases, evade resistance
2014-04-17
CHAMPAIGN, Ill. — A drug under clinical trials to treat tuberculosis could be the basis for a class of broad-spectrum drugs that act against various bacteria, fungal infections and parasites, yet evade resistance, according to a study by University of Illinois chemists and collaborators.
Led by U. of I. chemistry professor Eric Oldfield, the team determined the different ways the drug SQ109 attacks the tuberculosis bacterium, how the drug can be tweaked to target other pathogens from yeast to malaria – and how targeting multiple pathways reduces the probability of pathogens ...
Study recalculates costs of combination vaccines
2014-04-17
CHAMPAIGN, Ill. — One of the most popular vaccine brands for children may not be the most cost-effective choice. And doctors may be overlooking some cost factors when choosing vaccines, driving the market toward what is actually a more expensive option, according to a new study by University of Illinois researchers.
"The choice of vaccines to administer can be driven by numerous factors," says Sheldon H. Jacobson, a co-author of the study and a professor of computer science and of mathematics at the U. of I. "In an environment where vaccines are under growing public scrutiny, ...
Feinstein Institute researcher publishes new perspective on sepsis
2014-04-17
MANHASSET, NY – In a review published in the April issue of Immunity, Kevin J. Tracey, MD, president of The Feinstein Institute for Medical Research, says it's time to take a fresh look at the medical community's approach to treating sepsis, which kills millions worldwide every year, including more than 200,000 Americans.
Sepsis occurs when molecules released into the bloodstream to fight an injury or infection trigger inflammation throughout the body. Inflammation is necessary for maintaining good health – without inflammation, wounds and infections would never be ...
McCullers reviews influenza, bacterial superinfections in Nature Reviews Microbiology
2014-04-17
Le Bonheur Children's Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited to submit a review in the April issue of Nature Reviews Microbiology, one of the world's foremost scientific publications. Dr. McCullers, a world-renowned infectious disease specialist, and chair of the Department of Pediatrics at the University of Tennessee Health Science Center, analyzed the epidemiology and microbiology of co-infections during the 1918, 1957 and 1968 pandemics, as well as more recent 2009 novel H1N1 pandemic.
He reviewed the co-pathogenesis of influenza viruses ...
Building 'smart' cell-based therapies
2014-04-17
A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other sites of disease.
Engineering cell-based, biological devices that monitor and modify human physiology is a promising frontier in clinical synthetic biology. However, no existing technology enabled bioengineers to build such devices that sense a patient's physiological state and respond in a customized fashion.
"The project addressed a key gap in the synthetic biology ...